IL175026A0 - Use of metallic cations to improve functional activity of antibodies - Google Patents

Use of metallic cations to improve functional activity of antibodies

Info

Publication number
IL175026A0
IL175026A0 IL175026A IL17502606A IL175026A0 IL 175026 A0 IL175026 A0 IL 175026A0 IL 175026 A IL175026 A IL 175026A IL 17502606 A IL17502606 A IL 17502606A IL 175026 A0 IL175026 A0 IL 175026A0
Authority
IL
Israel
Prior art keywords
antibodies
functional activity
metallic cations
improve functional
improve
Prior art date
Application number
IL175026A
Other languages
English (en)
Original Assignee
Lab Francais Du Fractionnement
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lab Francais Du Fractionnement filed Critical Lab Francais Du Fractionnement
Publication of IL175026A0 publication Critical patent/IL175026A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Transplantation (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
IL175026A 2003-10-20 2006-04-20 Use of metallic cations to improve functional activity of antibodies IL175026A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0312228A FR2861079B1 (fr) 2003-10-20 2003-10-20 Utilisation de cations metalliques divalents pour l'amelioration de l'activite fonctionnelle des anticorps.
PCT/FR2004/002687 WO2005040216A2 (fr) 2003-10-20 2004-10-20 Utilisation de cations metalliques pour cristalliser le fragment fc d’un anticorps rhesus d

Publications (1)

Publication Number Publication Date
IL175026A0 true IL175026A0 (en) 2006-08-20

Family

ID=34385293

Family Applications (1)

Application Number Title Priority Date Filing Date
IL175026A IL175026A0 (en) 2003-10-20 2006-04-20 Use of metallic cations to improve functional activity of antibodies

Country Status (8)

Country Link
EP (1) EP1689785A2 (fr)
JP (1) JP2007537990A (fr)
AU (1) AU2004283925A1 (fr)
BR (1) BRPI0415620A (fr)
CA (1) CA2542928A1 (fr)
FR (1) FR2861079B1 (fr)
IL (1) IL175026A0 (fr)
WO (1) WO2005040216A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2894982A1 (fr) * 2005-12-16 2007-06-22 Lab Francais Du Fractionnement Procede de preparation d'anticorps selectifs des recepteurs fc activateurs
FR2942799B1 (fr) * 2009-03-06 2011-02-25 Lfb Biotechnologies Anticorps monoclonal anti-rhesus d
EP2787006B1 (fr) * 2013-04-02 2018-02-28 Miltenyi Biotec GmbH Anticorps anti-CD8 dont la liaison dépend de Ca2+

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2081213A1 (fr) * 1990-05-08 1991-11-09 Richard A. Lerner Proteines capables de liaison avec les metaux
US5898067A (en) * 1997-02-07 1999-04-27 Novo Nordisk A/S Crystallization of proteins
FR2807767B1 (fr) * 2000-04-12 2005-01-14 Lab Francais Du Fractionnement Anticorps monoclonaux anti-d
FR2894982A1 (fr) * 2005-12-16 2007-06-22 Lab Francais Du Fractionnement Procede de preparation d'anticorps selectifs des recepteurs fc activateurs

Also Published As

Publication number Publication date
AU2004283925A1 (en) 2005-05-06
JP2007537990A (ja) 2007-12-27
FR2861079B1 (fr) 2007-09-28
FR2861079A1 (fr) 2005-04-22
WO2005040216A2 (fr) 2005-05-06
WO2005040216A3 (fr) 2005-10-20
EP1689785A2 (fr) 2006-08-16
BRPI0415620A (pt) 2006-12-12
CA2542928A1 (fr) 2005-05-06

Similar Documents

Publication Publication Date Title
TWI366570B (en) Antibodies to madcam
EP1535930A4 (fr) Anticorps specifique a une proteine-tetra centrale
PL1768999T3 (pl) Przeciwciało sHIgM12 użyteczne w leczeniu stwardnienia rozsianego
EP1778957A4 (fr) Optimisation de la mesure d'emissions radioactives dans des structures corporelles specifiques
AU2003286922A8 (en) Analysis of geometric surfaces by conformal structure
EP1591527A4 (fr) Substance specifique a pd-1 humain
AU2003295411A8 (en) Human monoclonal antibodies to heparanase
IL191340A (en) Monoclonal antibodies against e8o
IL189788A0 (en) Human monoclonal antibodies to cd70
EP1503795A4 (fr) Utilisation de proteines du stress en vue d'ameliorer l'efficacite de la therapeutique anticorps
SI1587542T1 (sl) Uporaba anti-cd100 protiteles
EP1755661A4 (fr) Utilisation de gelsoline pour le traitement d'infections
PL1625166T3 (pl) Przeciwciała przeciwko masp-2
ZA200802641B (en) Human monoclonal antibodies to CD70
EP1789027A4 (fr) Utilisation therapeutique d'anticorps d'antigene anti-tf
GB0307671D0 (en) Improvements relating to the construction of playing surfaces
AU2003234706A8 (en) Antibodies that specifically bind to tl5
IL172276A0 (en) Cross-reference to related application
PT1781145T (pt) Ferramenta para facilitar o consumo de substâncias ingeríveis
IL174827A0 (en) Antibodies to nik preparation and use
EG26100A (en) Unit to increase urea production
GB0305363D0 (en) Improvements relating to skin prickers
HK1155670A1 (en) Therapeutic use of anti-cs1 antibodies
AU2003302822A8 (en) Antibodies to treat cancer
IL175026A0 (en) Use of metallic cations to improve functional activity of antibodies